Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Volitionrx (VNRX) Revenue (2019 - 2025)

Volitionrx (VNRX) has disclosed Revenue for 9 consecutive years, with $422905.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Revenue fell 10.88% year-over-year to $422905.0, compared with a TTM value of $1.1 million through Sep 2025, down 14.0%, and an annual FY2024 reading of $1.2 million, up 59.1% over the prior year.
  • Revenue was $422905.0 for Q3 2025 at Volitionrx, up from $244910.0 in the prior quarter.
  • Across five years, Revenue topped out at $474522.0 in Q3 2024 and bottomed at $14240.0 in Q4 2021.
  • Average Revenue over 5 years is $174707.4, with a median of $165211.0 recorded in 2023.
  • The sharpest move saw Revenue surged 4593.01% in 2021, then tumbled 38.12% in 2025.
  • Year by year, Revenue stood at $14240.0 in 2021, then surged by 740.7% to $119715.0 in 2022, then surged by 103.79% to $243973.0 in 2023, then fell by 21.44% to $191657.0 in 2024, then skyrocketed by 120.66% to $422905.0 in 2025.
  • Business Quant data shows Revenue for VNRX at $422905.0 in Q3 2025, $244910.0 in Q2 2025, and $246385.0 in Q1 2025.